RCM
SRTA

Radcliffe Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Radcliffe Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-705,010
Closed -$7.08M – 356
2020
Q3 		$7.08M Buy
705,010
+294,886
+72% +$2.98M 0.64% 23
2020
Q2 		$4.09M Hold
410,124
– – 0.56% 38
2020
Q1 		$3.97M Buy
+410,124
New +$4.07M 0.73% 29

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Radcliffe Capital Management's SRTA Position: Q4 2020 in Review

Radcliffe Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2020, closing a stake of 705,010 shares — an estimated $7.08M sold.

Radcliffe Capital Management first reported a position in SRTA in Q1 2020 and held it in 3 quarters. The position peaked at $7.08M in Q3 2020. 84 funds tracked by Wall St. Rank hold SRTA as of Q4 2020.

  • Radcliffe Capital Management reported no remaining Strata Critical Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Radcliffe Capital Management sold 705,010 Strata Critical Medical Inc shares in Q4 2020, an estimated $7.08M.
  • Radcliffe Capital Management first reported a position in Strata Critical Medical Inc in Q1 2020 and held it in 3 quarters.
  • Radcliffe Capital Management's Strata Critical Medical Inc position peaked at $7.08M in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2020.

Based on Radcliffe Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.